These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 27477002)

  • 1. Pharmacotherapy for the management of cancer regimen-related oral mucositis.
    Villa A; Sonis ST
    Expert Opin Pharmacother; 2016 Sep; 17(13):1801-7. PubMed ID: 27477002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies.
    Elad S; Yarom N; Zadik Y; Kuten-Shorrer M; Sonis ST
    CA Cancer J Clin; 2022 Jan; 72(1):57-77. PubMed ID: 34714553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polaprezinc prevents oral mucositis in patients treated with high-dose chemotherapy followed by hematopoietic stem cell transplantation.
    Hayashi H; Kobayashi R; Suzuki A; Ishihara M; Nakamura N; Kitagawa J; Kanemura N; Kasahara S; Kitaichi K; Hara T; Tsurumi H; Moriwaki H; Itoh Y
    Anticancer Res; 2014 Dec; 34(12):7271-7. PubMed ID: 25503160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral mucositis in myelosuppressive cancer therapy.
    Epstein JB; Schubert MM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Sep; 88(3):273-6. PubMed ID: 10503852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging therapies for the prevention and treatment of oral mucositis.
    Yuan A; Sonis S
    Expert Opin Emerg Drugs; 2014 Sep; 19(3):343-51. PubMed ID: 25102771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
    Chaudhry HM; Bruce AJ; Wolf RC; Litzow MR; Hogan WJ; Patnaik MS; Kremers WK; Phillips GL; Hashmi SK
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):605-616. PubMed ID: 26409924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy- and radiotherapy-induced oral mucositis: pathobiology, epidemiology and management.
    Feller L; Essop R; Wood NH; Khammissa RA; Chikte UM; Meyerov R; Lemmer J
    SADJ; 2010 Sep; 65(8):372-4. PubMed ID: 21133051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary study in a new protocol for the treatment of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT).
    Vitale MC; Modaffari C; Decembrino N; Zhou FX; Zecca M; Defabianis P
    Lasers Med Sci; 2017 Aug; 32(6):1423-1428. PubMed ID: 28664389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy- and radiotherapy-induced oral mucositis: review of preventive strategies and treatment.
    Saadeh CE
    Pharmacotherapy; 2005 Apr; 25(4):540-54. PubMed ID: 15977916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucositis associated with stem cell transplantation: current status and innovative approaches to management.
    Stiff P
    Bone Marrow Transplant; 2001 May; 27 Suppl 2():S3-S11. PubMed ID: 11436115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-induced oral mucositis. Prevention and management.
    Knox JJ; Puodziunas AL; Feld R
    Drugs Aging; 2000 Oct; 17(4):257-67. PubMed ID: 11087004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis.
    Hong BY; Sobue T; Choquette L; Dupuy AK; Thompson A; Burleson JA; Salner AL; Schauer PK; Joshi P; Fox E; Shin DG; Weinstock GM; Strausbaugh LD; Dongari-Bagtzoglou A; Peterson DE; Diaz PI
    Microbiome; 2019 Apr; 7(1):66. PubMed ID: 31018870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biological basis for the attenuation of mucositis: the example of interleukin-11.
    Sonis S; Edwards L; Lucey C
    Leukemia; 1999 Jun; 13(6):831-4. PubMed ID: 10360368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.
    Stiff PJ; Emmanouilides C; Bensinger WI; Gentile T; Blazar B; Shea TC; Lu J; Isitt J; Cesano A; Spielberger R
    J Clin Oncol; 2006 Nov; 24(33):5186-93. PubMed ID: 16391299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management.
    Epstein JB; Schubert MM
    Oncology (Williston Park); 2003 Dec; 17(12):1767-79; discussion 1779-82, 1791-2. PubMed ID: 14723014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis.
    Scully C; Epstein J; Sonis S
    Head Neck; 2003 Dec; 25(12):1057-70. PubMed ID: 14648865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal damage: a major risk factor for severe complications after cytotoxic therapy.
    Peterson DE; Cariello A
    Semin Oncol; 2004 Jun; 31(3 Suppl 8):35-44. PubMed ID: 15181607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral mucositis in cancer therapy.
    Sonis ST
    J Support Oncol; 2004; 2(6 Suppl 3):3-8. PubMed ID: 15605918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Effect of Polaprezinc, a Zinc-L-carnosine, Against Chemotherapy-induced Oral Mucositis in Pediatric Patients Undergoing Autologous Stem Cell Transplantation.
    Funato M; Ozeki M; Suzuki A; Ishihara M; Kobayashi R; Nozawa A; Yasue S; Endo-Ohnishi S; Fukao T; Itoh Y
    Anticancer Res; 2018 Aug; 38(8):4691-4697. PubMed ID: 30061237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II investigational oral drugs for the treatment of radio/chemotherapy induced oral mucositis.
    Sonis ST; Villa A
    Expert Opin Investig Drugs; 2018 Feb; 27(2):147-154. PubMed ID: 29323575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.